Aehr Test Systems plans sale of 40,000 shares

Aehr Test Systems (AEHR) filed a notice of proposed sale under Rule 144 for up to 40,000 shares of common stock to be sold through Fidelity Brokerage Services LLC on 08/12/2026 on NASDAQ, with an aggregate market value of $5,233,716.34.

Rhea-AI Filing Summary

Aehr Test Systems (AEHR) filed a notice of proposed sale under Rule 144 for up to 40,000 shares of common stock to be sold through Fidelity Brokerage Services LLC on 08/12/2026 on NASDAQ, with an aggregate market value of $5,233,716.34. The filing also lists prior issuances of common stock as compensation via restricted stock vesting on several dates in 2021 and 2022, including 28,168 shares on 08/13/2021, 2,082 shares on 04/01/2022, 5,489 shares on 04/20/2022, 2,044 shares on 07/13/2022, and 2,217 shares on 10/03/2022.

Key Figures

Shares to be sold: 40,000 shares Aggregate market value: $5,233,716.34 Shares outstanding: 32,620,450 shares +3 more

6 metrics

Shares to be sold 40,000 shares Common stock proposed for sale under Rule 144

Aggregate market value $5,233,716.34 Estimated value of 40,000 shares to be sold

Shares outstanding 32,620,450 shares Common shares outstanding for the class referenced

Planned sale date 08/12/2026 Approximate date of proposed NASDAQ sale

Restricted stock vesting 08/13/2021 28,168 shares Common stock issued as compensation on 08/13/2021

Restricted stock vesting 04/20/2022 5,489 shares Common stock issued as compensation on 04/20/2022

Key Terms

Rule 144, restricted stock vesting, aggregate market value, common stock

4 terms

Rule 144 regulatory

"Aehr Test Systems filed a notice of proposed sale under Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"The filing also lists prior issuances of common stock as compensation via restricted stock vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

aggregate market value financial

"with an aggregate market value of $5,233,716.34"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

common stock financial

"up to 40,000 shares of common stock to be sold"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AEHR shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of 40,000 shares of Aehr Test Systems common stock. These shares are expected to be sold through Fidelity Brokerage Services LLC on NASDAQ around 08/12/2026, subject to Rule 144 conditions.

What is the aggregate market value of the AEHR shares in this Form 144?

The aggregate market value of the 40,000 shares of Aehr Test Systems common stock is listed as $5,233,716.34. This value reflects the estimated market value at the time of the filing for the proposed Rule 144 sale.

When is the planned sale date for the AEHR shares in this Form 144?

The approximate planned sale date for the Aehr Test Systems shares is 08/12/2026. The filing indicates the shares may be sold on NASDAQ through Fidelity Brokerage Services LLC around that date, consistent with Rule 144 requirements.

Which broker is named for the AEHR Form 144 sale?

The filing names Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, as the broker for the proposed sale of 40,000 shares of Aehr Test Systems common stock on NASDAQ.

What prior AEHR restricted stock vesting events are disclosed?

The filing lists several restricted stock vesting events for Aehr Test Systems common stock: 28,168 shares on 08/13/2021, 2,082 on 04/01/2022, 5,489 on 04/20/2022, 2,044 on 07/13/2022, and 2,217 on 10/03/2022 as compensation.

How many AEHR common shares are shown as outstanding in this Form 144?

The document shows 32,620,450 Aehr Test Systems common shares outstanding. This figure provides context for the relative size of the proposed 40,000-share sale, which represents only a small portion of the total outstanding shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/12/2026 - 03:02 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001364097
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AEHR TEST SYSTEMS
SEC File Number	000-22893
Address of Issuer	400 KATO TERRACE FREMONT CALIFORNIA 94539
Phone	5106239400
Name of Person for Whose Account the Securities are To Be Sold	Erickson Gayn
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	40000	5233716.34	32620450	08/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/13/2021	Restricted Stock Vesting	Issuer			28168	08/13/2021	Compensation
Common	04/01/2022	Restricted Stock Vesting	Issuer			2082	04/01/2022	Compensation
Common	04/20/2022	Restricted Stock Vesting	Issuer			5489	04/20/2022	Compensation
Common	07/13/2022	Restricted Stock Vesting	Issuer			2044	07/13/2022	Compensation
Common	10/03/2022	Restricted Stock Vesting	Issuer			2217	10/03/2022	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Today's sale took place in the Gaylord And Tricia Erickson Revocable Trust account in which Gaylord L. Erickson is trustee.
Date of Notice	08/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Gaylord L.Erickson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)